William Blair Cuts Earnings Estimates for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at William Blair lowered their Q2 2025 earnings per share estimates for shares of DENTSPLY SIRONA in a research report issued on Thursday, February 27th. William Blair analyst B. Vazquez now anticipates that the medical instruments supplier will post earnings per share of $0.44 for the quarter, down from their prior estimate of $0.52. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2025 earnings at $0.51 EPS, FY2025 earnings at $1.80 EPS, Q2 2026 earnings at $0.47 EPS, Q3 2026 earnings at $0.54 EPS, Q4 2026 earnings at $0.61 EPS and FY2026 earnings at $1.93 EPS.

Other equities analysts have also recently issued research reports about the stock. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday. UBS Group lowered their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research note on Friday. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $23.58.

DENTSPLY SIRONA Stock Down 3.4 %

Shares of XRAY stock opened at $15.99 on Monday. DENTSPLY SIRONA has a one year low of $15.94 and a one year high of $34.28. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a fifty day moving average price of $18.83 and a 200 day moving average price of $21.46. The stock has a market cap of $3.18 billion, a P/E ratio of -7.72, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently bought and sold shares of the company. Vise Technologies Inc. bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of DENTSPLY SIRONA by 13.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock valued at $10,466,000 after purchasing an additional 65,308 shares in the last quarter. Voloridge Investment Management LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $24,571,000. Tidal Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 15.5% during the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock worth $488,000 after buying an additional 3,449 shares in the last quarter. Finally, True Wealth Design LLC lifted its position in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 1,950 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.00%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.